# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367644-22-000070
Filing Date
2022-04-29
Accepted
2022-04-28 17:44:29
Documents
118
Period of Report
2022-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | ebs-20220331.htm iXBRL | 10-Q | 1735214
2 | EX-10.1 | biothraxcontractmod27edg.htm | EX-10.1 | 4692
3 | EX-10.3 | fehconsulting.htm | EX-10.3 | 58475
4 | EX-31.1 | a311-kramercert111.htm | EX-31.1 | 8594
5 | EX-31.2 | a312-lindhalcert111.htm | EX-31.2 | 8660
6 | EX-32.1 | a321-kramercert111.htm | EX-32.1 | 3632
7 | EX-32.2 | a322-lindhalcert111.htm | EX-32.2 | 3492
13 | GRAPHIC | biothraxcontractmod27edg001.jpg | GRAPHIC | 223760
14 | GRAPHIC | ebs-20220331_g1.jpg | GRAPHIC | 75656
15 | GRAPHIC | ebs-20220331_g2.jpg | GRAPHIC | 47961
16 | GRAPHIC | ebs-20220331_g3.jpg | GRAPHIC | 27878
17 | GRAPHIC | ebs-20220331_g4.jpg | GRAPHIC | 28279
18 | GRAPHIC | ebs-20220331_g5.jpg | GRAPHIC | 29233
19 | GRAPHIC | ebs-20220331_g6.jpg | GRAPHIC | 26736
20 | GRAPHIC | ebs-20220331_g7.jpg | GRAPHIC | 24031
21 | GRAPHIC | ebs-20220331_g8.jpg | GRAPHIC | 30199
22 | GRAPHIC | ebs-20220331_g9.jpg | GRAPHIC | 24528
23 | GRAPHIC | fehconsulting001.jpg | GRAPHIC | 247250
24 | GRAPHIC | fehconsulting002.jpg | GRAPHIC | 311862
25 | GRAPHIC | fehconsulting003.jpg | GRAPHIC | 335169
26 | GRAPHIC | fehconsulting004.jpg | GRAPHIC | 306193
27 | GRAPHIC | fehconsulting005.jpg | GRAPHIC | 315388
28 | GRAPHIC | fehconsulting006.jpg | GRAPHIC | 302390
29 | GRAPHIC | fehconsulting007.jpg | GRAPHIC | 321634
30 | GRAPHIC | fehconsulting008.jpg | GRAPHIC | 262818
31 | GRAPHIC | fehconsulting009.jpg | GRAPHIC | 281514
32 | GRAPHIC | fehconsulting010.jpg | GRAPHIC | 119540
33 | GRAPHIC | fehconsulting011.jpg | GRAPHIC | 51631
34 | GRAPHIC | fehconsulting012.jpg | GRAPHIC | 189965
35 | GRAPHIC | fehconsulting013.jpg | GRAPHIC | 134979
36 | GRAPHIC | fehconsulting014.jpg | GRAPHIC | 50518
37 | GRAPHIC | fehconsulting015.jpg | GRAPHIC | 280472
38 | GRAPHIC | fehconsulting016.jpg | GRAPHIC | 117502
39 | GRAPHIC | fehconsulting017.jpg | GRAPHIC | 237009
40 | GRAPHIC | fehconsulting018.jpg | GRAPHIC | 263888
41 | GRAPHIC | fehconsulting019.jpg | GRAPHIC | 72704
| Complete submission text file | 0001367644-22-000070.txt |  | 14562101

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | ebs-20220331.xsd | EX-101.SCH | 44466
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | ebs-20220331_cal.xml | EX-101.CAL | 71645
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | ebs-20220331_def.xml | EX-101.DEF | 259614
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | ebs-20220331_lab.xml | EX-101.LAB | 587434
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | ebs-20220331_pre.xml | EX-101.PRE | 427742
112 | EXTRACTED XBRL INSTANCE DOCUMENT | ebs-20220331_htm.xml | XML | 1293659

Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33137 | Film No.: 22868438
SIC: 2834 Pharmaceutical Preparations